One of the largest breakthroughs in treating CF was the implementation of ivacaftor, a CFTR potentiator, which increases CFTR activity by improving the ion channel gating (Van Goor et al., 2009)
Preclinical studies demonstrate that DSIP can alter pain threshold responses, with observed effects that are not reversed by opioid receptor antagonists such as naloxone, suggesting involvement of non-opioid or indirect neuromodulatory pathways [7]
It simply enhances the bodys natural GH release patterns, which means: No shutdown of the HPA or HPG axis No elevation in cortisol or prolactin No increased risk of gynecomastia , mood swings, or adrenal fatigue This safety profile makes Ipamorelin especially attractive for long-term wellness, anti-aging, or physique-enhancement strategies
However, the manufacturers COA that Letco received, did not contain a similar statement